Efficacy and Safety of DEB-TACE Combined With HAIC Versus HAIC Alone in Patients With Unresectable CRLM
NCT07031570
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
500
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer Metastatic
Sponsor
Peking University Cancer Hospital & Institute